Journal Article

Nevirapine or Lamivudine plus Stavudine and Indinavir: Examples of 2-Class versus 3-Class Regimens for the Treatment of Human Immunodeficiency Virus Type 1

Odile Launay, Laurence Gérard, Laurence Morand-Joubert, Philippe Flandre, Sonia Guiramand-Hugon, Véronique Joly, Gilles Peytavin, Agnàs Certain, Claude Lévy, Stéphane Rivet, Christine Jacomet, Jean-Pierre Aboulker and Patrick Yéni

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 35, issue 9, pages 1096-1105
Published in print November 2002 | ISSN: 1058-4838
Published online November 2002 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/342694
Nevirapine or Lamivudine plus Stavudine and Indinavir: Examples of 2-Class versus 3-Class Regimens for the Treatment of Human Immunodeficiency Virus Type 1

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

We compared use of a 3-class regimen (nevirapine [Nvp], stavudine [d4T], and indinavir [Idv; 1000 mg 3 times daily]) with use of a 2-class regimen (lamivudine [3TC], d4T, and Idv [800 mg 3 times daily]) for 145 patients infected with human immunodeficiency virus type 1 (HIV-1). At week 72, the plasma HIV-1 RNA level was undetectable in 52% of Nvp recipients versus 79% of 3TC recipients (P < .001). Idv trough levels were 81 ng/mL in the Nvp group and 99 ng/mL in the 3TC group (P = .012). In the Nvp group, 42.5% of patients discontinued the study regimen; in the 3TC group, 22.5% of patients discontinued therapy (P = .013). The rate of resistance to nonnucleoside analogue reverse-transcriptase inhibitors among patients in the Nvp group with virological failure was not different from the rate of resistance to 3TC among patients in the 3TC group with virological failure. These results do not support the use of a 3-class regimen that includes Nvp for patients with no or limited exposure to nucleoside analogues.

Journal Article.  5954 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.